119 related articles for article (PubMed ID: 18483087)
1. Synthesis and evaluation of a series of 99mTc(CO)3+ lisinopril complexes for in vivo imaging of angiotensin-converting enzyme expression.
Femia FJ; Maresca KP; Hillier SM; Zimmerman CN; Joyal JL; Barrett JA; Aras O; Dilsizian V; Eckelman WC; Babich JW
J Nucl Med; 2008 Jun; 49(6):970-7. PubMed ID: 18483087
[TBL] [Abstract][Full Text] [Related]
2. Molecular imaging of human ACE-1 expression in transgenic rats.
Dilsizian V; Zynda TK; Petrov A; Ohshima S; Tahara N; Haider N; Donohue A; Aras O; Femia FJ; Hillier SM; Joyal JL; Wong ND; Coleman T; Babich JW; Narula J
JACC Cardiovasc Imaging; 2012 Apr; 5(4):409-18. PubMed ID: 22498331
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of angiotensin-converting enzyme and attenuation of myocardial fibrosis by lisinopril in rats receiving angiotensin II.
Sun Y; Ratajska A; Weber KT
J Lab Clin Med; 1995 Jul; 126(1):95-101. PubMed ID: 7602241
[TBL] [Abstract][Full Text] [Related]
4. Evidence for tissue angiotensin-converting enzyme in explanted hearts of ischemic cardiomyopathy using targeted radiotracer technique.
Dilsizian V; Eckelman WC; Loredo ML; Jagoda EM; Shirani J
J Nucl Med; 2007 Feb; 48(2):182-7. PubMed ID: 17268012
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of CXCR4 expression in myocardial infarction using 99mTc-labeled SDF-1alpha.
Misra P; Lebeche D; Ly H; Schwarzkopf M; Diaz G; Hajjar RJ; Schecter AD; Frangioni JV
J Nucl Med; 2008 Jun; 49(6):963-9. PubMed ID: 18483105
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m labeled 1-(4-fluorobenzyl)-4-(2-mercapto-2-methyl-4-azapentyl)-4-(2-mercapto-2-methylpropylamino)-piperidine and iodine-123 metaiodobenzylguanidine for studying cardiac adrenergic function: a comparison of the uptake characteristics in vascular smooth muscle cells and neonatal cardiac myocytes, and an investigation in rats.
Samnick S; Scheuer C; Münks S; El-Gibaly AM; Menger MD; Kirsch CM
Nucl Med Biol; 2004 May; 31(4):511-22. PubMed ID: 15093822
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
Udupa EG; Rao NM
Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
[TBL] [Abstract][Full Text] [Related]
8. Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice.
Campbell DJ; Alexiou T; Xiao HD; Fuchs S; McKinley MJ; Corvol P; Bernstein KE
Hypertension; 2004 Apr; 43(4):854-9. PubMed ID: 14769811
[TBL] [Abstract][Full Text] [Related]
9. Targeted catalytic inactivation of angiotensin converting enzyme by lisinopril-coupled transition-metal chelates.
Joyner JC; Hocharoen L; Cowan JA
J Am Chem Soc; 2012 Feb; 134(7):3396-410. PubMed ID: 22200082
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic evaluation of lisinopril-tryptophan, a novel C-domain ACE inhibitor.
Denti P; Sharp SK; Kröger WL; Schwager SL; Mahajan A; Njoroge M; Gibhard L; Smit I; Chibale K; Wiesner L; Sturrock ED; Davies NH
Eur J Pharm Sci; 2014 Jun; 56():113-9. PubMed ID: 24561703
[TBL] [Abstract][Full Text] [Related]
11. Specificity of diastereomers of [99mTc]TRODAT-1 as dopamine transporter imaging agents.
Meegalla SK; Plössl K; Kung MP; Stevenson DA; Mu M; Kushner S; Liable-Sands LM; Rheingold AL; Kung HF
J Med Chem; 1998 Feb; 41(4):428-36. PubMed ID: 9484494
[TBL] [Abstract][Full Text] [Related]
12. Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors.
Johnston CI; Fabris B; Yamada H; Mendelsohn FA; Cubela R; Sivell D; Jackson B
J Hypertens Suppl; 1989 Sep; 7(5):S11-6. PubMed ID: 2553899
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biologic evaluation of monocationic asymmetric 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties.
Boschi A; Uccelli L; Bolzati C; Duatti A; Sabba N; Moretti E; Di Domenico G; Zavattini G; Refosco F; Giganti M
J Nucl Med; 2003 May; 44(5):806-14. PubMed ID: 12732683
[TBL] [Abstract][Full Text] [Related]
14. Surface plasmon resonance analysis of the binding mechanism of pharmacological and peptidic inhibitors to human somatic angiotensin I-converting enzyme.
Zidane F; Zeder-Lutz G; Altschuh D; Girardet JM; Miclo L; Corbier C; Cakir-Kiefer C
Biochemistry; 2013 Dec; 52(48):8722-31. PubMed ID: 24168709
[TBL] [Abstract][Full Text] [Related]
15. Cardiac and renal distribution of ACE and ACE-2 in rats with heart failure.
Cohen-Segev R; Francis B; Abu-Saleh N; Awad H; Lazarovich A; Kabala A; Aronson D; Abassi Z
Acta Histochem; 2014 Oct; 116(8):1342-9. PubMed ID: 25217176
[TBL] [Abstract][Full Text] [Related]
16. Impact of bidentate chelators on lipophilicity, stability, and biodistribution characteristics of cationic 99mTc-nitrido complexes.
Kim YS; He Z; Hsieh WY; Liu S
Bioconjug Chem; 2007; 18(3):929-36. PubMed ID: 17352455
[TBL] [Abstract][Full Text] [Related]
17. 99mTc carbonyl t-butyl isonitrile: a potential new agent for myocardial perfusion imaging.
Kothari KK; Satpati D; Joshi S; Venkatesh M; Ramamoorthy N; Pillai MR
Nucl Med Commun; 2005 Feb; 26(2):155-61. PubMed ID: 15657510
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized rats.
Windt WA; van Dokkum RP; Kluppel CA; Jeronimus-Stratingh CM; Hut F; de Zeeuw D; Henning RH
Eur J Pharmacol; 2008 Feb; 580(1-2):231-40. PubMed ID: 18036585
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and pre-clinical evaluation of (99m) Tc-tricarbonyl complexes as potential myocardial perfusion imaging agents.
Ellis BL; Gorshkov NI; Lumpov AA; Miroslavov AE; Yalfimov AN; Gurzhiy VV; Suglobov DN; Braddock R; Adams JC; Smith AM; Prescott MC; Sharma HL
J Labelled Comp Radiopharm; 2013 Dec; 56(14):700-7. PubMed ID: 24339008
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
